drugset / Trial / NCT00904397
Lidocaine Patch 5% Versus Celecoxib 200 mg in Chronic Axial Low Back Pain
RandomizedParallel-groupDouble-blindTreatment
Summary
Patients who had axial lower back pain (LBP) with or without radiation present for at least 3 months and had daily moderate to severe LBP as the primary source of pain participated in a Phase IV clinical trial to assess the efficacy of lidocaine patch 5% compared to celecoxib 200 mg in treating chronic axial LBP with and without radiation.
Timeline
- Start
- 2004-07
- Primary completion
- 2004-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Celecoxib | Other / unclassified | 200 mg | Oral |
| Subject | Lidocaine | Other / unclassified | 5 % | Topical |